Practice
Featured experience
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
PGT Innovations $3.1 billion acquisition by MITER Brands
We are advising PGT Innovations on the transaction
AssetMark $2.7 billion acquisition by GTCR
We are advising AssetMark on the transaction
Barratt Developments £2.52 billion all-share offer for Redrow
We are advising UBS as financial adviser and sponsor to Barratt Developments on the transaction
Perella Weinberg sale of Agility to Cerity Partners
We are advising Perella Weinberg on the transaction
Nuvei $6.3 billion going-private acquisition
We are advising Nuvei on the transaction
AnHeart Therapeutics acquisition by Nuvation Bio
We are advising AnHeart Therapeutics on the acquisition
Doma take-private acquisition by Title Resources Group
We are advising Doma on the transaction
Crane NXT $270 million acquisition of OpSec Security
We are advising Crane NXT on the acquisition
Sonae cash tender offer for Musti Group
We are advising Sonae on the tender offer
TASK Group Holdings AU$310 million acquisition by PAR Technology
We are advising TASK on the transaction
Mongolian Mining sale of 20% of Khangad Exploration
We are advising MMC on the transaction